Tempest Therapeutics (TPST) Net Margin Growth (3y) (2018)
Tempest Therapeutics (TPST) Net Margin Growth (3y) (2018) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.40 Bn | 131.55 Bn | 2.84 Bn | -374.00 |
| 2 | Regeneron Pharmaceuticals | 86.53 Bn | 78.54 Bn | 3.93 Bn | -44.00 |
| 3 | Argenx Se | 65.20 Bn | 60.02 Bn | 1.37 Bn | -389.00 |
| 4 | Moderna | 60.40 Bn | 55.26 Bn | 52.00 Mn | -13,815.00 |
| 5 | BeOne Medicines | 42.17 Bn | 37.07 Bn | 1.53 Bn | 7,793.00 |
| 6 | Alnylam Pharmaceuticals | 31.36 Bn | 28.05 Bn | 992.69 Mn | 9,934.00 |
| 7 | BioNTech SE | 28.74 Bn | 10.34 Bn | 668.28 Mn | -11,156.00 |
| 8 | Insmed | 27.45 Bn | 26.29 Bn | 358.27 Mn | 31,387.00 |
| 9 | Royalty Pharma | 27.17 Bn | 26.33 Bn | - | -5,319.00 |
| 10 | Tempest Therapeutics | 4.38 Mn | 3.58 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2018 | 1.36 Mn |
| Jun 30, 2018 | 4.88 Mn |
| Mar 31, 2018 | 10.37 Mn |